Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$11.9M Buy
223,642
+20,092
+10% +$1.12M 0.21% 110
2014
Q3
$11.7M Buy
203,550
+9,801
+5% +$601K 0.22% 109
2014
Q2
$13M Buy
193,749
+43,194
+29% +$2.92M 0.23% 90
2014
Q1
$10.1M Sell
150,555
-50,678
-25% -$3.43M 0.19% 114
2013
Q4
$13.4M Buy
201,233
+17,479
+10% +$1.13M 0.22% 101
2013
Q3
$11.5M Buy
183,754
+60,589
+49% +$3.9M 0.22% 106
2013
Q2
$7.69M Buy
+123,165
New +$7.82M 0.16% 157

Other funds holding GSK

Placemark Investments's GSK Position: Q4 2014 in Review

Placemark Investments increased its GSK (GSK) stake by 9.9% in Q4 2014, buying an estimated $1.12M and bringing the position to 223,642 shares worth $11.9M. The position accounts for 0.21% of the portfolio, ranked #110.

Placemark Investments first reported a position in GSK in Q2 2013 and has held it in 7 quarters since. The position peaked at $13.4M in Q4 2013. 728 funds tracked by Wall St. Rank hold GSK as of Q4 2014.

  • Placemark Investments held 223,642 shares of GSK worth $11.9M as of Q4 2014.
  • Placemark Investments bought 20,092 GSK shares in Q4 2014, an estimated $1.12M.
  • GSK made up 0.21% of Placemark Investments's portfolio in Q4 2014, its #110 holding.
  • Placemark Investments first reported a position in GSK in Q2 2013 and has held it in 7 quarters since.
  • Placemark Investments's GSK position peaked at $13.4M in Q4 2013.
  • 728 funds tracked by Wall St. Rank held GSK as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.